*THIS SESSION WILL BE PRESENTED DURING THE LIFE SCIENCES FUTURE - BIOPHARM CONFERENCE.* If you would like to view the full conference, please register using the link here - https://life-sciences-pennsylvania.ticketleap.com/life-sciences-future---biopharm-2022/
Phase to Phase - The Guide to Drug Development
FlowMetric’s expertise includes Discovery / Lead Optimization, Pre-clinical Tox, Translational, and Clinical Trials.
Session Topic – Discovery: The do’s and don’t’s, experience perspective, and recognition of workarounds that enable the process.
- Target Identification
- Target Validation
- Hit Identification/Lead Discovery
- Assay Development
- Lead Optimization
- Mark Tornetta, MS, Vice President of Lead Discovery, Tavotek Biotherapeutics
- Julie Bick, Ph.D., Chief Scientific Officer, FlowMetric, a KCAS company
- Dominic Warrino, Ph.D., Senior Scientific Adviser, KCAS Bioanalytical & Biomarker Services
- Moderator: Ren Capocasale, Vice Chair & Founder, FlowMetric, a KCAS company
Refund/cancellation policy: This program is offered free of charge. As such refunds are not applicable. Questions: Contact Lauren Boyle, [email protected]